Overview

Effect of Interleukin-6 Receptor Inhibition in Patients With Ischemic Stroke Undergoing Endovascular Treatment

Status:
COMPLETED
Trial end date:
2024-09-22
Target enrollment:
Participant gender:
Summary
Tocilizumab may exert neuroprotective effects in patients with ischemic stroke undergoing endovascular treatment
Phase:
PHASE2
Details
Lead Sponsor:
Suzhou Municipal Hospital of Anhui Province
Collaborator:
Xuanwu Hospital, Beijing
Treatments:
tocilizumab